FDA — Fidia SpA Cashflow Statement
0.000.00%
Last trade - 00:00
- €3.94m
- €7.51m
- €24.37m
- 29
- 69
- 15
- 27
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.55 | -4.48 | -5.95 | -3.5 | 5.75 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.641 | -0.623 | -0.674 | 0.045 | -10.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.65 | 5.66 | 7.74 | 1.89 | 3.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.59 | 2.91 | 3.77 | 0.584 | 0.793 |
Capital Expenditures | -1.77 | -0.894 | -0.499 | -0.086 | -0.298 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.036 | — | 0.318 | 0.029 | 0.067 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -1.73 | -0.894 | -0.181 | -0.057 | -0.231 |
Financing Cash Flow Items | -0.036 | -0.17 | 0.036 | -0.182 | 1.44 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.95 | -4.17 | -1.47 | -1.09 | 0.747 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.08 | -2.01 | 1.6 | 0.384 | 1.69 |